PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
2,816,210
Share change
-264,538
Total reported value
$28,409,688
Price per share
$10.09
Number of holders
43
Value change
-$4,519,146
Number of buys
20
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q2 2019

As of 30 Jun 2019, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,816,210 shares. The largest 10 holders included KENNEDY CAPITAL MANAGEMENT, INC., RENAISSANCE TECHNOLOGIES LLC, Tieton Capital Management, LLC, CRAWFORD INVESTMENT COUNSEL INC, VANGUARD GROUP INC, DEPRINCE RACE & ZOLLO INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., Uniplan Investment Counsel, Inc., and North Star Investment Management Corp.. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.